State Street Corp increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% during the first quarter, Holdings Channel reports. The institutional investor owned 45,724,509 shares of the healthcare conglomerate’s stock after buying an additional 1,122,534 shares during the period. UnitedHealth Group makes up about 0.7% of State Street Corp’s portfolio, making the stock its 28th largest position. State Street Corp’s holdings in UnitedHealth Group were worth $7,499,276,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the stock. Quadrant Capital Group LLC increased its position in shares of UnitedHealth Group by 4.4% in the first quarter. Quadrant Capital Group LLC now owns 4,244 shares of the healthcare conglomerate’s stock valued at $684,000 after buying an additional 180 shares during the period. Gulf International Bank UK Ltd increased its position in shares of UnitedHealth Group by 2.9% in the first quarter. Gulf International Bank UK Ltd now owns 300,307 shares of the healthcare conglomerate’s stock valued at $49,253,000 after buying an additional 8,593 shares during the period. Raymond James Trust N.A. increased its position in shares of UnitedHealth Group by 0.8% in the first quarter. Raymond James Trust N.A. now owns 55,809 shares of the healthcare conglomerate’s stock valued at $9,153,000 after buying an additional 456 shares during the period. Osborn Williams & Donohoe LLC increased its position in shares of UnitedHealth Group by 31.7% in the first quarter. Osborn Williams & Donohoe LLC now owns 12,796 shares of the healthcare conglomerate’s stock valued at $2,099,000 after buying an additional 3,080 shares during the period. Finally, Paradigm Financial Advisors LLC increased its position in shares of UnitedHealth Group by 0.4% in the first quarter. Paradigm Financial Advisors LLC now owns 2,761 shares of the healthcare conglomerate’s stock valued at $452,000 after buying an additional 11 shares during the period. 86.37% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Incorporated (UNH) traded up 0.23% during midday trading on Friday, reaching $193.02. The company’s stock had a trading volume of 2,210,720 shares. UnitedHealth Group Incorporated has a 1-year low of $132.39 and a 1-year high of $196.04. The stock’s 50-day moving average price is $189.36 and its 200 day moving average price is $174.75. The firm has a market capitalization of $186.62 billion, a PE ratio of 23.19 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. The business had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.96 EPS. Equities analysts anticipate that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This report was originally posted by Daily Political and is owned by of Daily Political. If you are viewing this report on another publication, it was illegally copied and republished in violation of U.S. and international trademark and copyright laws. The original version of this report can be accessed at https://www.dailypolitical.com/2017/08/12/state-street-corp-has-7-50-billion-position-in-unitedhealth-group-incorporated-unh.html.

Several equities analysts have commented on the company. Cowen and Company reaffirmed an “outperform” rating and issued a $220.00 price objective (up previously from $175.00) on shares of UnitedHealth Group in a research report on Friday. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $215.00 price objective on the stock in a research report on Tuesday, August 1st. Oppenheimer Holdings, Inc. reaffirmed an “outperform” rating and issued a $205.00 price objective (up previously from $203.00) on shares of UnitedHealth Group in a research report on Friday, July 21st. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $210.00 price objective (up previously from $190.00) on shares of UnitedHealth Group in a research report on Saturday, July 22nd. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $208.00 price objective on shares of UnitedHealth Group in a research report on Friday, July 21st. One investment analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $202.20.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the transaction, the director now directly owns 75,735 shares of the company’s stock, valued at approximately $13,832,240.40. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction dated Friday, June 2nd. The stock was sold at an average price of $178.74, for a total value of $990,219.60. Following the transaction, the director now directly owns 60,516 shares of the company’s stock, valued at $10,816,629.84. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,540 shares of company stock valued at $2,873,320. Insiders own 0.89% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.